Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 14 crawled time : 01:00 save search
Everest Medicines Announces the Acceptance of a New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer in South Korea
Published: 2021-12-14 (Crawled : 01:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
new drug application drug cancer negative breast cancer
Geron Reports Presentations at American Society of Hematology Annual Meeting
Published: 2021-12-14 (Crawled : 01:00) - biospace.com/
GERN | $3.69 -1.07% -1.08% 8.2M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
ema presentation
Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis
Published: 2021-12-14 (Crawled : 01:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -2.07%
H: 0.0%
C: 0.0%
genomic diagnostic
Route 92 Medical Raises $111 Million in Combined Series E and Debt FinancingPlans to execute the SUMMIT MAX trial to obtain FDA clearance for the proprietary Route 92 Medical Reperfusion System
Published: 2021-12-14 (Crawled : 01:00) - biospace.com/
RWAY | $12.57 -0.4% -0.4% 230K
|
|
| O: 0.94%
H: 0.0%
C: 0.0%
fda clearance trial fda clearance
RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Active Psoriatic Arthritis
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
rinvoq fda fda approval approval
New Snowflake Features Released In October And November 2021
Published: 2021-12-14 (Crawled : 01:00) - snowflake.com
SNOW | News | $145.45 -1.99% -0.08% 5M
|
Technology Services
|
| O: -5.72%
H: 3.97%
C: 1.89%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -1.43%
H: 2.97%
C: 0.13%
Innovent Announces Pivotal Phase 2 Results for Parsaclisib (PI3Kδ inhibitor) Presented at ASH 2021 Show Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.82%
H: 0.92%
C: 0.66%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.76%
H: 3.79%
C: 1.89%
phase 2 phase 2 results results
Female Infertility Drugs Market to Grow by USD 538.69 mn | AbbVie Inc. and Aurobindo Pharma Ltd. Among Key Vendors | Technavio
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 0.5%
C: -0.43%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
ema drug pharma
Viracta Therapeutics Presents Preclinical Vecabrutinib Data in Oral and Poster Presentations at ASH 2021
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
VIRX | $0.88 -3.19% -3.3% 53K
|
Manufacturing
|
| O: -9.07%
H: 2.16%
C: -8.36%
therapeutics presentation preclinical pre-clinical
Alcoa Set to Join S&P MidCap 400
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
|
| O: -0.21%
H: 0.48%
C: -1.14%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 2.79%
H: 0.64%
C: -0.87%
AA | News | $35.53 0.17% 0.0% 8M
|
Non-Energy Minerals
|
| O: -0.53%
H: 4.33%
C: 3.06%
set
TransAlta Declares Dividends
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
TAC | News | $6.45 0.31% 0.0% 1M
|
Utilities
|
| O: -1.18%
H: 0.0%
C: 0.0%
Mercado Libre announces the acquisition of Redelcom to strengthen its strategy in payment systems
Published: 2021-12-14 (Crawled : 01:00) - globenewswire.com
MELI | $1356.2 -1.03% -1.04% 360K
|
Technology Services
|
| O: 1.51%
H: 3.09%
C: 2.85%
acquisition
Update on Novartis Agreement
Published: 2021-12-14 (Crawled : 01:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 0.5%
C: -0.43%
MESO | $5.19 1.57% 1.54% 230K
|
Health Technology
|
| O: -21.49%
H: 0.56%
C: -12.21%
novartis
Alamos Gold Announces Exercise of Red Pine Exploration Inc. Warrants
Published: 2021-12-14 (Crawled : 01:00) - globenewswire.com
AGI | News | $15.295 1.56% 0.1% 2.2M
|
Non-Energy Minerals
|
| O: -0.84%
H: 1.06%
C: -0.85%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.